Search Results - Fraser Cunningham
- Showing 1 - 4 results of 4
-
1
Experience from an HTS campaign: Investigation of susceptibility and rescue of SARS-CoV-2 nsp3 protease assay from metal contamination by Irene Georgiou, Sandra O’Neill, Colin Robinson, Fraser Cunningham, Sean N. O’Byrne, David Gray, Ian H. Gilbert, Duncan E. Scott
Published in SLAS Technology (2026-05-01)Get full text
Article -
2
Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies by Loveleena Bansal, Eva-Maria Nichols, Daniel P. Howsmon, Jessica Neisen, Christina M. Bessant, Fraser Cunningham, Sebastien Petit-Frere, Steve Ludbrook, Valeriu Damian
Published in Frontiers in Pharmacology (2022-04-01)Get full text
Article -
3
Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent. by Henok Asfaw, Katja Laqua, Anna Maria Walkowska, Fraser Cunningham, Maria Santos Martinez-Martinez, Juan Carlos Cuevas-Zurita, Lluís Ballell-Pages, Peter Imming
Published in PLoS ONE (2017-01-01)Get full text
Article -
4
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies. by Lee A Armstrong, Sven M Lange, Virginia Dee Cesare, Stephen P Matthews, Raja Sekhar Nirujogi, Isobel Cole, Anthony Hope, Fraser Cunningham, Rachel Toth, Rukmini Mukherjee, Denisa Bojkova, Franz Gruber, David Gray, Paul G Wyatt, Jindrich Cinatl, Ivan Dikic, Paul Davies, Yogesh Kulathu
Published in PLoS ONE (2021-01-01)Get full text
Article
